Public signalCompany raiseAuto-indexed · Unverified

NEURONA THERAPEUTICS, INC raised $120.0M

NEURONA THERAPEUTICS, INC· SOUTH SAN FRANCISCO, US· Biotechnology· Filed Feb 13, 2024

NEURONA THERAPEUTICS, INC reported raising capital. Based in SOUTH SAN FRANCISCO, CALIFORNIA, US. First sale reported 2024-02-06. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$120.0M
Confidence90%
Raised
$120.0M
Investors
35
Jurisdiction
DELAWARE

On the record

Location
SOUTH SAN FRANCISCO, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$120.0M
Target amount
$120.0M
Filing date
Feb 13, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Biotechnology
Number of investors
35
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$120.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 119,999,974 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Feb 13, 2024. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnologyOver $100MCompany Raise

Are you associated with NEURONA THERAPEUTICS, INC?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record